webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Boc-Phe-(Alloc)Lys-PAB-PNP

  CAS No.: 1160844-44-9   Cat No.: BADC-00490   Purity: ≥98% 4.5  

Boc-Phe-(Alloc)Lys-PAB-PNP is a complex biomedical compound being investigated as an innovative treatment for a variety of diseases, especially cancer. Known for its powerful properties, it effectively halts tumor progression through targeted neutralization of unique enzymes and pathways.

Boc-Phe-(Alloc)Lys-PAB-PNP

Structure of 1160844-44-9

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C38H45N5O11
Molecular Weight
747.79
Shipping
Room temperature, or blue ice upon request.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
[4-[[(2S)-1-amino-1-oxo-6-(prop-2-enoxycarbonylamino)hexan-2-yl]-[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate;
IUPAC Name
[4-[[(2S)-1-amino-1-oxo-6-(prop-2-enoxycarbonylamino)hexan-2-yl]-[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]phenyl]methyl (4-nitrophenyl) carbonate
Canonical SMILES
CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C(=O)N(C2=CC=C(C=C2)COC(=O)OC3=CC=C(C=C3)[N+](=O)[O-])C(CCCCNC(=O)OCC=C)C(=O)N
InChI
InChI=1S/C38H45N5O11/c1-5-23-51-35(46)40-22-10-9-13-32(33(39)44)42(34(45)31(24-26-11-7-6-8-12-26)41-36(47)54-38(2,3)4)28-16-14-27(15-17-28)25-52-37(48)53-30-20-18-29(19-21-30)43(49)50/h5-8,11-12,14-21,31-32H,1,9-10,13,22-25H2,2-4H3,(H2,39,44)(H,40,46)(H,41,47)/t31-,32-/m0/s1
InChIKey
ZFWAEVQMHYNGJL-ACHIHNKUSA-N
Appearance
Soild powder
Shipping
Room temperature, or blue ice upon request.

Boc-Phe-(Alloc)Lys-PAB-PNP, a versatile chemical reagent, finds wide application in peptide synthesis and biochemical research.

Solid-Phase Peptide Synthesis: Playing a pivotal role in solid-phase peptide syntheses, Boc-Phe-(Alloc)Lys-PAB-PNP simplifies the assembly of intricate peptide chains. This reagent facilitates precise and effective coupling reactions during the synthesis process, enabling researchers to craft peptides with meticulously defined sequences for diverse biological experiments.

Drug Development: In the arena of pharmaceutical research, this reagent serves as a cornerstone in the creation of peptide-based drug candidates. By incorporating Boc-Phe-(Alloc)Lys-PAB-PNP, scientists can engineer peptides with promising therapeutic attributes. These artificially synthesized peptides undergo rigorous testing to evaluate their efficacy and safety as potential drug candidates, driving innovation in the field of medicine.

Proteomics: Embraced by the discipline of proteomics, Boc-Phe-(Alloc)Lys-PAB-PNP aids in the production of crucial peptide standards. These standards play a pivotal role in mass spectrometry-based proteomic analyses, facilitating the identification and quantification of proteins in complex biological samples. The meticulous synthesis of peptides using this reagent ensures the precision and reliability of proteomic investigations.

Chemical Biology: Within the realm of chemical biology, this reagent emerges as a valuable asset for crafting peptide probes and inhibitors. Researchers leverage Boc-Phe-(Alloc)Lys-PAB-PNP to synthesize peptides capable of selectively binding to or impeding specific proteins. These tailored peptide probes serve as indispensable instruments for investigating protein functionality and interactions within intricate biological systems, unveiling novel insights into the molecular world.

1. Synthesis of different types of dipeptide building units containing N- or C-terminal arginine for the assembly of backbone cyclic peptides
L Seyfarth, S Reissmann, C Schumann, G Greiner J Pept Res . 2000 Jun;55(6):428-35. doi: 10.1034/j.1399-3011.2000.00719.x.
Different types of dipeptide building units containing N- or C-terminal arginine were prepared for synthesis of the backbone cyclic analogues of the peptide hormone bradykinin (BK: Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg). For cyclization in the N-terminal sequence N-carboxyalkyl and N-aminoalkyl functionalized dipeptide building units were synthesized. In order to avoid lactam formation during the condensation of the N-terminal arginine to the N-alkylated amino acids at position 2, the guanidino function has to be deprotected. The best results were obtained by coupling Z-Arg(Z)2-OH with TFFH/collidine in DCM. Another dipeptide building unit with an acylated reduced peptide bond containing C-terminal arginine was prepared to synthesize BK-analogues with backbone cyclization in the C-terminus. To achieve complete condensation to the resin and to avoid side reactions during activation of the arginine residue, this dipeptide unit was formed on a hydroxycrotonic acid linker. HYCRAM technology was applied using the Boc-Arg(Alloc)2-OH derivative and the Fmoc group to protect the aminoalkyl function. The reduced peptide bond was prepared by reductive alkylation of the arginine derivative with the Boc-protected amino aldehyde, derived from Boc-Phe-OH. The best results for condensation of the branching chain to the reduced peptide bond were obtained using mixed anhydrides. Both types of dipeptide building units can be used in solid-phase synthesis in the same manner as amino acid derivatives.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: MTS-4-NHS | Patritumab deruxtecan | Azido-PEG7-amine | Gly-NH-CH2-Boc | Py-MAA-Val-Cit-PAB-MMAE | Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 | (2R,10S)-10-Benzyl-2-cyclopropyl-23-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-6,9,12,15,18-pentaoxo-3-oxa-5,8,11,14,17-pentaazatricosanoic acid | Mal-di-PEG-Val-Cit-PAB | N3-PEG3-VC-PAB-MMAE | Mal-PEG6-NHS | Boc-Phe-(Alloc)Lys-PAB-PNP
Send Inquiry
Verification code
Inquiry Basket